Shaanxi Kanghui Pharm Co Ltd (603139) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.010x

Based on the latest financial reports, Shaanxi Kanghui Pharm Co Ltd (603139) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥7.14 Million ≈ $1.04 Million USD) by net assets (CN¥745.41 Million ≈ $109.08 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Shaanxi Kanghui Pharm Co Ltd for the company's overall valuation and market capitalisation.

Shaanxi Kanghui Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Shaanxi Kanghui Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shaanxi Kanghui Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shaanxi Kanghui Pharm Co Ltd ranked by their cash flow conversion efficiency. Explore 603139 cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Australian Agricultural Company Ltd
AU:AAC
0.001x
Nuveen Dynamic Municipal Opportunities Fund
NYSE:NDMO
0.036x
Consultatio SA
BA:CTIO
-0.228x
Bohai Ferry Co Ltd
SHG:603167
0.077x
Universal Cables Limited
NSE:UNIVCABLES
-0.002x
Saimo Electric Co Ltd
SHE:300466
-0.014x
WIA Gold Ltd
AU:WIA
-0.004x
Suzhou Alton Electrical & Mechanical Industry Co. Ltd.
SHE:301187
-0.070x

Annual Cash Flow Conversion Efficiency for Shaanxi Kanghui Pharm Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Shaanxi Kanghui Pharm Co Ltd from 2012 to 2025. View Shaanxi Kanghui Pharm Co Ltd share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥568.98 Million
≈ $83.26 Million
CN¥-16.72 Million
≈ $-2.45 Million
-0.029x -171.46%
2024-12-31 CN¥906.90 Million
≈ $132.71 Million
CN¥37.29 Million
≈ $5.46 Million
0.041x +158.14%
2023-12-31 CN¥1.02 Billion
≈ $149.25 Million
CN¥-72.13 Million
≈ $-10.56 Million
-0.071x -243.87%
2022-12-31 CN¥1.03 Billion
≈ $150.13 Million
CN¥50.43 Million
≈ $7.38 Million
0.049x +638.84%
2021-12-31 CN¥1.12 Billion
≈ $163.16 Million
CN¥7.42 Million
≈ $1.09 Million
0.007x -92.38%
2020-12-31 CN¥1.07 Billion
≈ $157.00 Million
CN¥93.72 Million
≈ $13.71 Million
0.087x -17.40%
2019-12-31 CN¥1.02 Billion
≈ $148.79 Million
CN¥107.53 Million
≈ $15.73 Million
0.106x +65.34%
2018-12-31 CN¥979.31 Million
≈ $143.30 Million
CN¥62.64 Million
≈ $9.17 Million
0.064x +33.81%
2017-12-31 CN¥912.11 Million
≈ $133.47 Million
CN¥43.60 Million
≈ $6.38 Million
0.048x -65.16%
2016-12-31 CN¥522.81 Million
≈ $76.50 Million
CN¥71.72 Million
≈ $10.49 Million
0.137x +120.22%
2015-12-31 CN¥457.58 Million
≈ $66.96 Million
CN¥28.50 Million
≈ $4.17 Million
0.062x +8.38%
2014-12-31 CN¥395.37 Million
≈ $57.86 Million
CN¥22.72 Million
≈ $3.33 Million
0.057x -51.42%
2013-12-31 CN¥332.63 Million
≈ $48.67 Million
CN¥39.35 Million
≈ $5.76 Million
0.118x +54.43%
2012-12-31 CN¥210.43 Million
≈ $30.79 Million
CN¥16.12 Million
≈ $2.36 Million
0.077x --

About Shaanxi Kanghui Pharm Co Ltd

SHG:603139 China Drug Manufacturers - Specialty & Generic
Market Cap
$554.37 Million
CN¥3.79 Billion CNY
Market Cap Rank
#11816 Global
#3388 in China
Share Price
CN¥37.93
Change (1 day)
-3.02%
52-Week Range
CN¥20.27 - CN¥45.21
All Time High
CN¥45.21
About

Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical intermediates in China. It is involved in the research, development, production, and sale of traditional Chinese medicine preparations; research and development of prepared slices of Chinese medicinal herbs and pharmaceutical intermediates; and pharmaceutical distribution of biolo… Read more